Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
SARS-CoV2 폐렴이 있는 중환자에서 보조 요법으로 CytoSorb를 사용한 혈액관류
Observational Study
[키워드] acute respiratory distress
acute respiratory distress syndrome
adjuvant
adjuvant therapy
Anticoagulant
Antiviral
approved
ARDS
Blood
Blood purification
C-reactive protein
cartridge
Case report
Clinical course
Clinical outcome
conducted
consecutive patient
Continuous Positive Airway Pressure
control patient
control patients
coronavirus
coronavirus 2
coronavirus disease
Course
COVID
COVID-19
COVID-19 patients
Critical illness
Critical illness cytokines
Cytokines
Cytosorb
develop
diagnosed
died
Effectiveness
effector
Evidence
greater
Hemoperfusion
Hospital admission
Hospitalized
IL-10
IL-6
IL-8
Ill
IMPROVE
include
Inflammation
inflammatory state
intensive care unit
Intubated
intubation
limited sample size
lymphocytopenia
Measures
mechanism
medical emergency
observational study
oxygen
oxygen supplementation
pathogenic
Patient
patients
Pneumonia
positive airway pressure
randomized clinical trial
remained
required
respiratory
respiratory distress
Respiratory function
respiratory specimens
reverse transcription-PCR
SARS-CoV2
scenario
sequence
severe acute respiratory distress syndrome
Severe acute respiratory syndrome
severe pneumonia
Study design
survived
syndrome
therapeutic
therapeutic strategy
therapy
tissue injury
TNF-α
treated
treated patient
treated patients
Treatment
virus
worsened
[DOI] 10.1159/000511725 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1159/000511725 PMC 바로가기 [Article Type] Observational Study